优特克单抗IV期临床试验中指甲银屑病治疗的指甲银屑病严重程度指数改善率标准的确定：MARCOPOLO研究 - Suppr | 超能文献

相似文献

1

Determination of the Nail Psoriasis Severity Index improvement rate standards for nail psoriasis treatment in a phase IV clinical trial of ustekinumab: the MARCOPOLO study.优特克单抗IV期临床试验中指甲银屑病治疗的指甲银屑病严重程度指数改善率标准的确定：MARCOPOLO研究

J Eur Acad Dermatol Venereol. 2017 Jun;31(6):e298-e299. doi: 10.1111/jdv.14083. Epub 2017 Jan 3.

2

Efficacy of ustekinumab in nail psoriasis and improvement in nail-associated quality of life in a population treated with ustekinumab for cutaneous psoriasis: an open prospective unblinded study.乌司奴单抗治疗皮肤银屑病人群中指甲银屑病的疗效及对指甲相关生活质量的改善：一项开放性前瞻性非盲研究。

Dermatology. 2011;223(4):325-9. doi: 10.1159/000334482. Epub 2011 Nov 30.

3

Dermoscopic features of nail psoriasis treated with biologics.使用生物制剂治疗的甲银屑病的皮肤镜特征。

J Dermatol. 2017 May;44(5):538-541. doi: 10.1111/1346-8138.13752. Epub 2017 Feb 2.

4

Ustekinumab improves nail disease in patients with moderate-to-severe psoriasis: results from PHOENIX 1.乌司奴单抗改善中重度银屑病患者的指甲疾病：来自 PHOENIX 1 的结果。

Br J Dermatol. 2014 Feb;170(2):398-407. doi: 10.1111/bjd.12632.

5

Comparison of NAPSI and N-NAIL for evaluation of fingernail psoriasis in patients with moderate-to-severe plaque psoriasis treated using ustekinumab.使用乌司奴单抗治疗的中度至重度斑块状银屑病患者中，比较NAPSI和N-NAIL对指甲银屑病的评估情况。

J Dermatolog Treat. 2019 Mar;30(2):123-128. doi: 10.1080/09546634.2018.1476649. Epub 2018 May 25.

6

Treatment of nail psoriasis with TNF-α or IL12/23 inhibitors.用肿瘤坏死因子-α或白细胞介素12/23抑制剂治疗甲银屑病。

J Drugs Dermatol. 2012 Aug;11(8):939-42.

7

Treatment of psoriasis and psoriatic arthritis with secukinumab after unsatisfactory response to ustekinumab in multiple sclerosis patient.在一名多发性硬化症患者对优特克单抗反应不佳后，使用司库奇尤单抗治疗银屑病和银屑病关节炎。

J Dermatol. 2019 Mar;46(3):e112-e113. doi: 10.1111/1346-8138.14619. Epub 2018 Aug 27.

8

Successful treatment of ustekinumab in a severe psoriasis patient with human immunodeficiency virus infection.优特克单抗成功治疗一名患有人类免疫缺陷病毒感染的重度银屑病患者。

J Eur Acad Dermatol Venereol. 2015 Aug;29(8):1653-5. doi: 10.1111/jdv.12531. Epub 2014 Apr 23.

9

Erythrodermic psoriasis treated with ustekinumab: an Italian multicenter retrospective analysis.乌司奴单抗治疗红皮病型银屑病：一项意大利多中心回顾性分析。

J Dermatol Sci. 2015 May;78(2):149-51. doi: 10.1016/j.jdermsci.2015.01.005. Epub 2015 Jan 28.

10

Safety of ustekinumab in severe psoriasis with chronic hepatitis B.优特克单抗在伴有慢性乙型肝炎的重度银屑病中的安全性。

Indian J Dermatol Venereol Leprol. 2016 May-Jun;82(3):326-8. doi: 10.4103/0378-6323.174393.

引用本文的文献

1

Clinical Trials in Nail Psoriasis: Cross-Sectional Analysis of the Current State of Research.指甲银屑病的临床试验：研究现状的横断面分析

Skin Appendage Disord. 2025 Jun;11(3):232-244. doi: 10.1159/000542568. Epub 2024 Nov 12.

2

Nail Psoriasis: Clinical Features and Severity Assessment.甲银屑病：临床特征与严重程度评估

Ann Dermatol. 2024 Aug;36(4):191-196. doi: 10.5021/ad.24.026.

3

Nail Psoriasis: An Updated Review of Currently Available Systemic Treatments.甲银屑病：当前可用全身治疗方法的最新综述